Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
Clinical trial NCT00081068 · WITHDRAWN
Trial details
- NCT number
- NCT00081068
- Sponsor
- Jonsson Comprehensive Cancer Center
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-01-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.